(Q44667891)

5 December 2017

title

The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy (English)

1 reference

5 December 2017

main subject

hippocampal sclerosis

1 reference

1

1 reference

5 December 2017

3

1 reference

5 December 2017

Michael R Trimble

2

1 reference

5 December 2017

publication date

1 December 2003

1 reference

5 December 2017

1 reference

5 December 2017

volume

44

1 reference

5 December 2017

issue

12

1 reference

5 December 2017

page(s)

1573-1577

1 reference

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Postmarketing experience with topiramate and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Topiramate and word-finding difficulties in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Topiramate and psychiatric adverse events in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Hippocampal changes in patients with a first episode of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Surgical treatment of drug-resistant epilepsy due to mesial temporal sclerosis. Etiology and significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Seizure characteristics, pathology, and outcome after temporal lobectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Characteristics of temporal lobe epilepsy with mesial temporal sclerosis, with special reference to psychotic episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

21 January 2018

Imaging and epilepsy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Clinical presentations in neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Depression and schizophrenia in epilepsy: social and biological risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0013-9580.2003.19103.X

10.1111/J.0013-9580.2003.19103.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference